Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05912413 · ClinicalTrials.gov registry record
Predicton of Sepsis Recovery Performance Subtypes Pilot Study
A clinical trial of Sepsis, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT05912413 is a study of Sepsis that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05912413, a study of Sepsis, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study addresses critically ill sepsis patients' current literature reports of ongoing post-hospital discharge weakness and hospital readmissions. This study is aimed at capture and interpretation of a complex set of tests, administered during a subject's sepsis functional recovery trajectory, particularly capturing hospital readmission's effects on survivors' physical function recovery.
Conditions Studied
Interventions
- OTHER there is no intervention
Study Locations (1)
Alabama
- University of Alabama at Birmingham (UAB) Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2027-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05912413
The ClinicalTrials.gov registry entry for NCT05912413 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which there is no intervention is the first listed.
NCT05912413 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05912413 about?
NCT05912413 is a clinical study titled "Predicton of Sepsis Recovery Performance Subtypes Pilot Study". This study addresses critically ill sepsis patients' current literature reports of ongoing post-hospital discharge weakness and hospital readmissions. This study is aimed at capture and interpretation of a complex set of tests, administered during a subject's sepsis functional recovery trajectory, p...
What is the current status of trial NCT05912413?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-07-11. Estimated completion is 2027-12-15.
What conditions does trial NCT05912413 study?
This clinical trial studies the following conditions: Sepsis.
What interventions are being tested in trial NCT05912413?
The interventions under investigation include: there is no intervention (OTHER).
Who is sponsoring clinical trial NCT05912413?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05912413 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.